Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Matthew L. Kaplan Insider Profile

4 Followers

Matthew L. Kaplan, Director at Nuvectis Pharma, holds 159.76K shares in Nuvectis Pharma (Ticker: NVCT).

Matthew L. Kaplan's Trading History

NVCTNuvectis Pharma		Jun 12, 2026DirectorUninformative Buy―$2.95M
NVCT
Insider Shares: 159.76K (0.60%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 12, 2026Uninformative Buy$0.0035,000$0.00―
Nov 06, 2025Informative Buy$64.24K11,000$5.84+225.90%
Jun 12, 2025Uninformative Buy$0.0030,000$0.00―
Jun 13, 2024Uninformative Buy$0.0030,000$0.00―
Jun 20, 2023Uninformative Buy$0.0018,000$0.00―
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Matthew L. Kaplan insider profile FAQ

What is the percentage of profitable transactions made by Matthew L. Kaplan?
The percentage of profitable transactions made by Matthew L. Kaplan is 50%.
What is the average return per transaction made by Matthew L. Kaplan?
The average return per transaction made by Matthew L. Kaplan is 107.40%.
What stocks does Matthew L. Kaplan hold?
Matthew L. Kaplan holds: NVCT stocks.
What was Matthew L. Kaplan's most profitable transaction?
Matthew L. Kaplan’s most profitable transaction was an Informative Buy of NVCT stock on November 6, 2025. The return on the trade was 225.90%.
What is Matthew L. Kaplan's role in Nuvectis Pharma?
Matthew L. Kaplan's role in Nuvectis Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.